3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Multiple Myeloma
15
Myelodysplastic Syndromes
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
5
Hematologic Neoplasms
5
Neuroblastoma
4
Myeloproliferative Disorders
4
Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Anemia, Refractory, with Excess of Blasts
4
Recurrence
3
Neoplasm, Residual
3
Leukemia, Myelomonocytic, Juvenile
3
Graft vs Host Disease
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Precancerous Conditions
2
Neoplasms, Plasma Cell
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Immunoblastic Lymphadenopathy
2
Interventions
Fluorouracil
14
Nivolumab
13
Oxaliplatin
12
Leucovorin
11
Paclitaxel
7
Capecitabine
7
pembrolizumab
6
Radiotherapy
5
Cisplatin
5
Taxes
4
Specimen Handling
4
Radiation
4
Irinotecan
4
Drug Therapy
4
dehydroftorafur
3
Trastuzumab
3
Ramucirumab
3
Magnetic Resonance Spectroscopy
3
Folfox protocol
3
zimberelimab
2
zanidatamab
2
trastuzumab deruxtecan
2
futibatinib
2
Levoleucovorin
2
Endoscopy, Digestive System
2
Endoscopy
2
Carboplatin
2
Biopsy
2
zolbetuximab
1
trastuzumab biosimilar HLX02
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Melphalan
×
90 days
×
Clear all
No trials found.